PERTUSSIS WHOLE CELL VACCINE - RELATION BETWEEN INTRACEREBRAL PROTECTION IN MICE AND ANTIBODY-RESPONSE TO PERTUSSIS TOXIN, FILAMENTOUS HEMAGGLUTININ AND ADENYLATE-CYCLASE

被引:0
作者
DELLEPIANE, NI
MANGHI, MA
ERIKSSON, PV
DIPAOLA, G
CANGELOSI, A
机构
[1] UNIV BUENOS AIRES,CONSEJO NACL INVEST CIENT & TECN,FAC FARM & BIOQUIM,RA-1113 BUENOS AIRES,ARGENTINA
[2] INST NACL MICROBIOL DR CARLOS G MALBRAN,DEPT CONTRALOR,RA-1281 BUENOS AIRES,ARGENTINA
来源
ZENTRALBLATT FUR BAKTERIOLOGIE-INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY VIROLOGY PARASITOLOGY AND INFECTIOUS DISEASES | 1992年 / 277卷 / 01期
关键词
D O I
暂无
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
N:NIH mice were vaccinated according to the WHO recommendations for the potency test with the Second International Standard for Pertussis Vaccine (ISPV). Blood for serological investigation was taken from the animals on day 14 post immunization before intracerebral challenge with Bordetella pertussis 18323 was done. The relationship between anti-pertussis toxin, anti-filamentous hemagglutinin and anti-adenylate cyclase antibody levels as measured by ELISA and protection from intracerebral challenge was studied. The proportion of surviving mice increased in correlation with increasing anti-PT titres; a protective level of 4 ELISA units/mt was found. Such relationship between protection against intracerebral challenge and antibody titres was not found for anti-FHA nor for anti-AC antibodies, thus suggesting that these antibodies do not play an important role in protection in this model. The excellent correlation between anti-PT antibody titres and protection suggests that the measure of anti-PT response could be a useful tool for estimating the potency of whole-cell vaccines. The development of an alternative method for testing the potency of pertussis whole-cell vaccines based on the anti-PT response should be considered.
引用
收藏
页码:65 / 73
页数:9
相关论文
共 33 条
  • [1] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [2] PROTECTIVE EFFECTS OF ANTI-BORDETELLA-PERTUSSIS ADENYLATE-CYCLASE ANTIBODIES AGAINST LETHAL RESPIRATORY-INFECTION OF THE MOUSE
    BREZIN, C
    GUISO, N
    LADANT, D
    DJAVADIOHANIANCE, L
    MEGRET, F
    ONYEOCHA, I
    ALONSO, JM
    [J]. FEMS MICROBIOLOGY LETTERS, 1987, 42 (01) : 75 - 80
  • [3] COWELL JL, 1982, SEMINARS INFECTIOUS, V4, P371
  • [4] AN AGGLUTININ-PRODUCTION TEST IN THE STUDY OF PERTUSSIS VACCINES
    EVANS, DG
    PERKINS, FT
    [J]. JOURNAL OF PATHOLOGY AND BACTERIOLOGY, 1953, 66 (02): : 479 - 488
  • [5] EVANS DG, 1955, BRIT J EXP PATHOL, V36, P391
  • [6] PURIFICATION AND ANALYSIS OF THE ANTIGENICITY OF A 69 000 DA PROTEIN FROM BORDETELLA-PERTUSSIS
    GOULDKOSTKA, JL
    BURNS, DL
    BRENNAN, MJ
    MANCLARK, CR
    [J]. FEMS MICROBIOLOGY LETTERS, 1990, 67 (03) : 285 - 290
  • [7] BORDETELLA ADENYLATE-CYCLASE IS A VIRULENCE ASSOCIATED FACTOR AND AN IMMUNOPROTECTIVE ANTIGEN
    GUISO, N
    ROCANCOURT, M
    SZATANIK, M
    ALONSO, JM
    [J]. MICROBIAL PATHOGENESIS, 1989, 7 (05) : 373 - 380
  • [8] HANOUNE J, 1977, J BIOL CHEM, V252, P2039
  • [9] EFFECT OF HEPTAKIS(2,6-O-DIMETHYL) BETA-CYCLODEXTRIN ON THE PRODUCTION OF PERTUSSIS TOXIN BY BORDETELLA-PERTUSSIS
    IMAIZUMI, A
    SUZUKI, Y
    ONO, S
    SATO, H
    SATO, Y
    [J]. INFECTION AND IMMUNITY, 1983, 41 (03) : 1138 - 1143
  • [10] LADANT D, 1988, J BIOL CHEM, V263, P2612